Novartis Aktie
98,83
EUR
±0,00
EUR
±0,00
%
92,29
CHF
-1,05
CHF
-1,12
%
Werbung
Novartis Aktie Analyse
31.08.05 | Novartis Peer Perform | Thomas Weisel Partners | |
26.08.05 | Novartis halten | National-Bank AG | |
09.08.05 | Novartis neutral | Nasd@q Inside | |
21.07.05 | Novartis halten | National-Bank AG | |
13.07.05 | Novartis neutral | HypoVereinsbank | |
12.07.05 | Novartis in-line | Goldman Sachs | |
11.07.05 | Novartis neutral | Bank Sarasin & Cie | |
22.06.05 | Novartis neutral | Bank Sarasin & Cie | |
Werbung
|
|||
16.06.05 | Novartis neutral | Robert W. Baird | |
10.06.05 | Novartis halten | Fuchsbriefe | |
08.06.05 | Novartis neutral | HypoVereinsbank | |
07.06.05 | Novartis neutral | Bank Sarasin & Cie | |
02.06.05 | Novartis neutral | Bank Sarasin & Cie | |
20.05.05 | Novartis | JRC | |
20.05.05 | Novartis | JRC | |
27.04.05 | Novartis Sector Perform | Vontobel | |
22.04.05 | Novartis Hold | SEB | |
21.04.05 | Novartis Neutral | Sarasin Research | |
18.04.05 | Novartis Neutral | JP Morgan | |
15.04.05 | Novartis Neutral | Sarasin Research | |
15.04.05 | Novartis Neutral | HypoVereinsbank | |
13.04.05 | Novartis Neutral | Sarasin Research | |
21.03.05 | Novartis Neutral | Sarasin Research | |
18.03.05 | Novartis Neutral | Sarasin Research | |
11.03.05 | Novartis Neutral | Sarasin Research | |
10.03.05 | Novartis Neutral | Sarasin Research | |
07.03.05 | Novartis Neutral | Sarasin Research | |
21.02.05 | Novartis Neutral | Sarasin Research | |
21.02.05 | Novartis Hold | SEB | |
26.01.05 | Novartis Market Perform | William Blair | |
25.01.05 | Novartis Halten | LB Baden-Württemberg | |
24.01.05 | Novartis Neutral | Sarasin Research | |
24.01.05 | Novartis Neutral | Sarasin Research | |
21.01.05 | Novartis Neutral | HypoVereinsbank | |
20.01.05 | Novartis Hold | SEB | |
20.01.05 | Novartis Neutral | Sarasin Research | |
19.01.05 | Novartis Equal-weight | Morgan Stanley | |
12.01.05 | Novartis Hold | Smith Barney Citigroup |
Werbung
Werbung